Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-11

Clinical Trial Update: Clinical Efficacy Of BioMin F, Colgate Sensitive Pro-Relief And Sensodyne Rapid Action Dentifrices In DH [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the clinical efficacy of BioMin F, Colgate Sensitive Pro-Relief, and Sensodyne Rapid Action dentifrices in dentin hypersensitivity has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BioMin F
  • Colgate Sensitive Pro-Relief
  • Sensodyne Rapid Action

Snippet

Sponsor: Dow University of Health Sciences | Conditions: Dentin Hypersensitivity | Phase 3 | Status: COMPLETED | Results posted: 2021-05-11